SlideShare a Scribd company logo
Repeated Dose Toxicity studies
(Subacute/Sub-chronic toxicity study)
Oral, Dermal and Inhalation routes
Dr. K. Nandakumar
Professor, Department of Pharmacology
MCOPS, MAHE, Manipal
Objectives of this Presentation
• The presentation will help the students of Master of Pharmacy (Pharmacology
and related disciplines) to comprehend the topic– ”Sub-acute toxicity studies” ,
in their curriculum. [PCI syllabus: Toxicological Screening Methods (MPL202T)].
• To describe how subacute toxicity studies are performed in industries, to meet
regulatory requirements.
• Describe OECD 407, 410 and 412 guidelines pertaining to repeated dose toxicities
of test chemicals administered via oral, dermal and inhalation routes.
Generally we adopt OECD guidelines
(1) The initial guidelines were published in 1981
(2) Revised in 1995 to include neuro and immunotoxicities.
(3) Ammended in 1998, to obtain information related to endocrine
disruptors
Oral route – Guideline no. 407 [28 d], 408 [90 d] (Rodents), 409 (Non-rodents)
Dermal route – Guidelines no. 410 [28 d], 411 [90 d],
Inhalation route – Guidelines no. 412 [28 d], 413 [90 d].
Principle of the Test
OECD 407 OECD 410 OECD 412
Test substance administered once
daily, by oral route, for 28 d.
Animals observed closely, each
day for signs of toxicity
Test substance administered dermally
for 28 days. Observed closely, each
day for signs of toxicity
Test substance - inhalation administered
for a defined period. Observed closely,
each day for signs of toxicity
Establish dose dependent relation-ship for the toxic effect
Allows to determination of the No-Observed Adverse Effect Level (NOAEL) and provide information on selection
of doses for long term studies
Selection and Preparation of Animals
OECD 407 OECD 410 ECD 412
Rats are the preferred species.
Lower species - increase variability: dissecting smaller organs.
Other species are accepted under suitable justification.
Young healthy adult animals of commonly used laboratory strains should be employed.
Females should be nulliparous and non pregnant.
The strain which has be adopted shall be in accordance to the chronic study.
Dosing should be initiated as early after the weaning period. At any case dosing should not be
delayed more than 9 weeks old.
Body weight variation should not exceed greater than 20%
Housing and Selection of doses
Husbandry conditions similar to Acute toxicity studies:
Temperature – 19 to 25o C, RH – 55%- 65% ; Light : dark- 12:12, Free
access to standard pellet and potable drinking water
Selection of doses: (Minimum 3 doses)
First High dose is decided
-
- This dose should induce
toxic effect but not severe
toxicity or death
- Toxicokinetic data, SAR,
Previous experience,
Efficacy study, LD10 may
help in predicting this
High DoseLow Dose Medium Dose
- Usually 2 to 4 times
reduced as compared to
the highest dose levels.
- Preferentially falls on the
human exposure dose.
- Should not produce any
observed toxic effect
- May be 10 times lower
than the medium dose
levels or higher dose
levels
Grouping and number of animals
25 males + 25 Females
Control
(5 M+ 5F)
Low dose
(5 M+5F)
Medium dose
(5M+5F)
High dose
(5M + 5F)
Satellite receives
high dose
(5M+5F)
5 groups
Additional animals can be kept in each group if interim sacrifices are planned. Exposure to various routes
is as per acute toxicity exposure.
Satellite groups helps to identify delayed type of toxicity and withdrawal effects. Limit dose studies can be
done at 1000 mg/kg
Mode of exposure of Test substance
OECD 407
Oral route
OECD 410
Dermal route
OECD 412
Inhalation route
Test substance - orally
administered for a defined period.
Observed closely, each day for
signs of toxicity
Test substance - skin administered
for a defined period. Observed
closely, each day for signs of toxicity
Test substance - inhalation administered
for a defined period. Observed closely,
each day for signs of toxicity
Observations
Daily observations:
Clinical observations, General health record of animals,
Mortality and morbidity
– Preferably at the same time on each day and at anticipated peak
period
Weekly observations:
- Body weight changes, Food and water intake
- Behavioral, neurological and autonomical profiles
End observations:
- Functional observations like grip strength, auditory, visual stimuli
etc.
- Vaginal smears, Blood collection, Gross necropsy and organ
collection
- Additional Blood sampling can be done to establish Toxicokinetics
and pharmacokinetics as per ICH guidelines
Parameters assessed
- Hematological parameters
- Clinical biochemistry
- Targeting to assess liver, kidney and heart functions
- Metabolic profiles and electrolyte balance
- Hormones and Endocrine related endpoints
- Wet weight of organs
- All the major weighable organs shall be weighed
- Expressed in terms of organ indices
- Gross necropsy and Histology of all the Organs.
- Satellite group will undergo the same procedure after 14 days of post
treatment. [28 +14 d]
THANK YOU

More Related Content

What's hot

Acute inhalational toxicity studies.pptx
 Acute inhalational toxicity studies.pptx Acute inhalational toxicity studies.pptx
Acute inhalational toxicity studies.pptx
Tanuj Silori
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on Toxicokinetics
Deepak Kumar
 
OECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityOECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicity
Shital Magar
 
Acute oral toxicity –acute class method
Acute oral toxicity –acute class methodAcute oral toxicity –acute class method
Acute oral toxicity –acute class method
Dr Ajay Mandal
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
pp_shivgunde
 
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Chetan Prakash
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies
Dinesh Gangoda
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
Kashikant Yadav
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testing
Sachin Sharma
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
Shikha Choudhary
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
SONALPANDE5
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
SONALPANDE5
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
AnimatedWorld
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
Santosh Sai
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
Anmolkanda06
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
Khadga Raj
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies
jeshicabulsara
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
Dr Ajay Mandal
 

What's hot (20)

Acute inhalational toxicity studies.pptx
 Acute inhalational toxicity studies.pptx Acute inhalational toxicity studies.pptx
Acute inhalational toxicity studies.pptx
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on Toxicokinetics
 
OECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicityOECD Guidline on acute and chronic toxicity
OECD Guidline on acute and chronic toxicity
 
Acute oral toxicity –acute class method
Acute oral toxicity –acute class methodAcute oral toxicity –acute class method
Acute oral toxicity –acute class method
 
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed DoseOECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
OECD Test Guideline 420: Acute Oral Toxicity - Fixed Dose
 
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
Toxicology | Definition | Types | Regulatory Guidelines | OECD Principles for...
 
Invivo Carcinogenecity Studies
Invivo Carcinogenecity StudiesInvivo Carcinogenecity Studies
Invivo Carcinogenecity Studies
 
Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies Dermal Irritation and Dermal Toxicity Studies
Dermal Irritation and Dermal Toxicity Studies
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testing
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIES
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
Acute dermal toxicity studies
Acute dermal toxicity studies Acute dermal toxicity studies
Acute dermal toxicity studies
 
Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405Acute eye irritation/corrosion- 405
Acute eye irritation/corrosion- 405
 

Similar to Repeated dose toxicity study

General toxicology
General toxicologyGeneral toxicology
General toxicology
Asif Yahya
 
TOXICOPHARMACOLOGY.pdf
TOXICOPHARMACOLOGY.pdfTOXICOPHARMACOLOGY.pdf
TOXICOPHARMACOLOGY.pdf
RAMDAS BHAT
 
Sub acute
Sub acuteSub acute
Toxicity testing
Toxicity testingToxicity testing
Toxicity testing
Jaineel Dharod
 
Chronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptxChronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptx
SIRAJUDDIN MOLLA
 
chronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECDchronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECD
Sohil Shah
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdf
ChijiokeNsofor
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
Urmila Aswar
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
PurushothamKN1
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
drkamalsahil
 
Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407
Tulsi Gulabrao Patil
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
Priya818982
 
Chronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlookChronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlook
RxVichuZ
 
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIESACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
Dr. Sindhu K., Asst. Prof., Dept. of VPT, VCG.
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
KhushbooThakur15
 
Oecd for chronic toxicity
Oecd for chronic toxicityOecd for chronic toxicity
Oecd for chronic toxicity
pavanreddy292
 
Toxicoloy
ToxicoloyToxicoloy
Toxicoloy
pradnya Jagtap
 
pharmacology practice school report.pptx
pharmacology practice school report.pptxpharmacology practice school report.pptx
pharmacology practice school report.pptx
Pharama slide share
 
pharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdf
pharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdfpharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdf
pharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdf
ManishJaat9
 

Similar to Repeated dose toxicity study (20)

General toxicology
General toxicologyGeneral toxicology
General toxicology
 
TOXICOPHARMACOLOGY.pdf
TOXICOPHARMACOLOGY.pdfTOXICOPHARMACOLOGY.pdf
TOXICOPHARMACOLOGY.pdf
 
Sub acute
Sub acuteSub acute
Sub acute
 
Toxicity testing
Toxicity testingToxicity testing
Toxicity testing
 
Chronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptxChronic Toxicity Study (OECD TG-452).pptx
Chronic Toxicity Study (OECD TG-452).pptx
 
chronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECDchronic dermal and inhalational studies as per OECD
chronic dermal and inhalational studies as per OECD
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdf
 
OECD Guidelines
OECD GuidelinesOECD Guidelines
OECD Guidelines
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 
Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407Subacute toxicity testing as per oecd guidelines tulsi 407
Subacute toxicity testing as per oecd guidelines tulsi 407
 
OECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptxOECD Dermal testing By Priya.pptx
OECD Dermal testing By Priya.pptx
 
Chronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlookChronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlook
 
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIESACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
 
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose ProcedureOECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
OECD Guideline 420: Acute oral Toxicity - Fixed Dose Procedure
 
Oecd for chronic toxicity
Oecd for chronic toxicityOecd for chronic toxicity
Oecd for chronic toxicity
 
Toxicoloy
ToxicoloyToxicoloy
Toxicoloy
 
pharmacology practice school report.pptx
pharmacology practice school report.pptxpharmacology practice school report.pptx
pharmacology practice school report.pptx
 
pharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdf
pharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdfpharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdf
pharmacologypracticeschoolreport-221219060301-1ca27004 (1).pdf
 

Recently uploaded

Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

Repeated dose toxicity study

  • 1. Repeated Dose Toxicity studies (Subacute/Sub-chronic toxicity study) Oral, Dermal and Inhalation routes Dr. K. Nandakumar Professor, Department of Pharmacology MCOPS, MAHE, Manipal
  • 2. Objectives of this Presentation • The presentation will help the students of Master of Pharmacy (Pharmacology and related disciplines) to comprehend the topic– ”Sub-acute toxicity studies” , in their curriculum. [PCI syllabus: Toxicological Screening Methods (MPL202T)]. • To describe how subacute toxicity studies are performed in industries, to meet regulatory requirements. • Describe OECD 407, 410 and 412 guidelines pertaining to repeated dose toxicities of test chemicals administered via oral, dermal and inhalation routes.
  • 3. Generally we adopt OECD guidelines (1) The initial guidelines were published in 1981 (2) Revised in 1995 to include neuro and immunotoxicities. (3) Ammended in 1998, to obtain information related to endocrine disruptors Oral route – Guideline no. 407 [28 d], 408 [90 d] (Rodents), 409 (Non-rodents) Dermal route – Guidelines no. 410 [28 d], 411 [90 d], Inhalation route – Guidelines no. 412 [28 d], 413 [90 d].
  • 4. Principle of the Test OECD 407 OECD 410 OECD 412 Test substance administered once daily, by oral route, for 28 d. Animals observed closely, each day for signs of toxicity Test substance administered dermally for 28 days. Observed closely, each day for signs of toxicity Test substance - inhalation administered for a defined period. Observed closely, each day for signs of toxicity Establish dose dependent relation-ship for the toxic effect Allows to determination of the No-Observed Adverse Effect Level (NOAEL) and provide information on selection of doses for long term studies
  • 5. Selection and Preparation of Animals OECD 407 OECD 410 ECD 412 Rats are the preferred species. Lower species - increase variability: dissecting smaller organs. Other species are accepted under suitable justification. Young healthy adult animals of commonly used laboratory strains should be employed. Females should be nulliparous and non pregnant. The strain which has be adopted shall be in accordance to the chronic study. Dosing should be initiated as early after the weaning period. At any case dosing should not be delayed more than 9 weeks old. Body weight variation should not exceed greater than 20%
  • 6. Housing and Selection of doses Husbandry conditions similar to Acute toxicity studies: Temperature – 19 to 25o C, RH – 55%- 65% ; Light : dark- 12:12, Free access to standard pellet and potable drinking water Selection of doses: (Minimum 3 doses) First High dose is decided - - This dose should induce toxic effect but not severe toxicity or death - Toxicokinetic data, SAR, Previous experience, Efficacy study, LD10 may help in predicting this High DoseLow Dose Medium Dose - Usually 2 to 4 times reduced as compared to the highest dose levels. - Preferentially falls on the human exposure dose. - Should not produce any observed toxic effect - May be 10 times lower than the medium dose levels or higher dose levels
  • 7. Grouping and number of animals 25 males + 25 Females Control (5 M+ 5F) Low dose (5 M+5F) Medium dose (5M+5F) High dose (5M + 5F) Satellite receives high dose (5M+5F) 5 groups Additional animals can be kept in each group if interim sacrifices are planned. Exposure to various routes is as per acute toxicity exposure. Satellite groups helps to identify delayed type of toxicity and withdrawal effects. Limit dose studies can be done at 1000 mg/kg
  • 8. Mode of exposure of Test substance OECD 407 Oral route OECD 410 Dermal route OECD 412 Inhalation route Test substance - orally administered for a defined period. Observed closely, each day for signs of toxicity Test substance - skin administered for a defined period. Observed closely, each day for signs of toxicity Test substance - inhalation administered for a defined period. Observed closely, each day for signs of toxicity
  • 9. Observations Daily observations: Clinical observations, General health record of animals, Mortality and morbidity – Preferably at the same time on each day and at anticipated peak period Weekly observations: - Body weight changes, Food and water intake - Behavioral, neurological and autonomical profiles End observations: - Functional observations like grip strength, auditory, visual stimuli etc. - Vaginal smears, Blood collection, Gross necropsy and organ collection - Additional Blood sampling can be done to establish Toxicokinetics and pharmacokinetics as per ICH guidelines
  • 10. Parameters assessed - Hematological parameters - Clinical biochemistry - Targeting to assess liver, kidney and heart functions - Metabolic profiles and electrolyte balance - Hormones and Endocrine related endpoints - Wet weight of organs - All the major weighable organs shall be weighed - Expressed in terms of organ indices - Gross necropsy and Histology of all the Organs. - Satellite group will undergo the same procedure after 14 days of post treatment. [28 +14 d]